FDA-Drug2026-04-15Class IIPROCESSING DEFECT

Fresenius Kabi sodium chloride injection recalled for sterility assurance issue

OTHERNationwide distributionDrugs

What this means

Fresenius Kabi USA is recalling specific batches of 0.9% Sodium Chloride Injection (a sterile saline solution) because the manufacturer cannot guarantee the product is free from contamination. The affected batches were distributed nationwide, including Alaska and Puerto Rico, between now and June 2027.

  • Check if you have any of the affected batch numbers (6402153, 6402297, 6402298, 6402377, 6402378, 6402379, 6402429, 6402430, 6402431, 6402432, 6402433, 6402434, 6402512, 6402574, or 6402576)
  • Do not use the product if you have an affected batch
  • Contact your pharmacy, hospital, or healthcare provider if you have received this product
  • Speak with your doctor or pharmacist about a safe replacement
The agency's original wording
Hazard

Lack of Assurance of Sterility

Intended for
All ages
Illnesses reported
None reported
Sold states
US Nationwide , Alaska, and Puerto Rico.
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Products
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-03.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0430-2026

More Fresenius Kabi recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime